Short Interest in AB Science S.A. (OTCMKTS:ABSCF) Rises By 27.2%

AB Science S.A. (OTCMKTS:ABSCF) saw a large increase in short interest in the month of June. As of June 15th, there was short interest totalling 33,700 shares, an increase of 27.2% from the May 31st total of 26,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

AB Science Stock Performance

ABSCF stock opened at $2.70 on Friday. The stock’s fifty day simple moving average is $2.70 and its 200-day simple moving average is $3.46. AB Science has a 52-week low of $2.55 and a 52-week high of $3.84.

AB Science Company Profile

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.